2m 2m 2m 2m 2m 2m 2m
SANA BIOTECH (SANA)
NASDAQ
$3.15+$0.02 (+0.64%)
Price as of Sep 11, 2026 7:56 PM EDT- $937.0MMarket Cap
- -2.80%1-Year Change
- BiotechnologyIndustry
SANA BIOTECH (SANA)
$3.15+$0.02 (+0.64%)
SANA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.13 | ||
Change | +$0.04 (+1.29%) | ||
Open | $3.13 | ||
High | $3.17 | ||
Low | $3.01 | ||
Previous Close | $3.09 | ||
Volume | 3,280,174 | ||
30-Day Average Volume | 2,972,138 | ||
1-Week Change | -18.70% | ||
1-Month Change | -17.41% | ||
1-Year Change | -2.80% | ||
3-Year Change | -43.81% | ||
5-Year Change | -87.36% | ||
Fundamentals | |||
Shares Outstanding | 299.4M | ||
Total Assets | $431.5M | ||
Market Cap | $937.0M | ||
Enterprise Value | $879.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$63.6M | ||
Free Cash Flow | -$34.4M | ||
EBIT | -$63.6M | ||
EBITDA | -$61.4M | ||
Net Working Capital | $46.9M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -14 | ||
PEG | 0 | ||
Price/Free Cash Flow | -27 | ||
Price/Operating Cash Flow | -29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue